Quick Facts
Generic NameDuloxetine
Brand NameCymbalta
Drug ClassSNRI
FDA Approved2004
Starting Dose30mg/day
Typical Range60–120mg/day
Max Dose120mg/day
Half-Life12 hours
MetabolismCYP1A2 (major), CYP2D6 (minor)
Generic Available2013
What Is Cymbalta?
Duloxetine (brand name Cymbalta) is a serotonin-norepinephrine reuptake inhibitor (SNRI) prescribed for depression, generalized anxiety, chronic pain + depression, and other psychiatric conditions. Only SNRI with FDA approval for pain conditions (fibromyalgia, diabetic neuropathy, chronic musculoskeletal pain). Dual mood + pain mechanism makes it uniquely valuable for depression with somatic symptoms.
At Psychiatry Telemed, duloxetine is prescribed and monitored by board-certified psychiatrists who understand the nuances of SNRI pharmacology — selecting the right dose, managing side effects, monitoring drug interactions, and optimizing your treatment through consistent monthly medication management appointments.
Duloxetine (Cymbalta) — SNRI medication for psychiatric care
ManufacturerEli Lilly
How Cymbalta Affects Neurotransmitters
How Cymbalta Works
Duloxetine inhibits reuptake of both serotonin and norepinephrine with relatively balanced potency at both transporters. This dual mechanism addresses both mood regulation and pain modulation — the descending norepinephrine and serotonin pathways from the brainstem also regulate pain perception.
Efficacy: Cymbalta vs. Comparators
Efficacy Comparison
Response & remission rates vs. comparators (Cipriani et al. meta-analysis)
Data from published meta-analyses. Individual response may vary.
Conditions Treated with Cymbalta
Depression
FDA-approved for MDD. Particularly effective when depression co-occurs with physical pain symptoms.
Learn About Depression →Generalized Anxiety
FDA-approved for GAD. Effective for both psychological and somatic anxiety symptoms.
Learn About Generalized Anxiety →Chronic Pain + Depression
FDA-approved for fibromyalgia and diabetic neuropathy. Unique dual benefit for pain + mood.
Learn About Chronic Pain + Depression →Musculoskeletal Pain
FDA-approved for chronic musculoskeletal pain. Valuable when stress produces physical pain.
Learn About Musculoskeletal Pain →Considering Cymbalta for Your Treatment?
Our board-certified psychiatrists can determine if duloxetine is right for you.
Dosage Information
| Indication | Starting Dose | Typical Range | Maximum |
|---|---|---|---|
| Depression | 30mg/day | 60–120mg/day | 120mg/day |
| Generalized Anxiety | 30mg/day | 60–120mg/day | 120mg/day |
| Chronic Pain + Depression | 30mg/day | 60–120mg/day | 120mg/day |
Brain Regions Targeted by Cymbalta
Side Effects
Like all medications, duloxetine has potential side effects. Most are mild, occur early in treatment, and often resolve within the first 1–2 weeks. Your psychiatrist monitors for side effects at every appointment.
Common Side Effects
NauseaHeadacheDrowsinessInsomniaDry MouthDizzinessSweating
Less Common Side Effects
ConstipationAppetite ChangesTremorSexual DysfunctionFatigue
Serious (Seek Immediate Help)
Serotonin SyndromeSevere Allergic ReactionSuicidal Thoughts (under 25)Abnormal Bleeding
Side Effect Profile: Cymbalta vs. Class Average
Side Effect Profile
Incidence rates from FDA prescribing information vs. class average
Percentages from clinical trial data. Actual experience may differ.
⚠️ FDA Black Box Warning
Antidepressants may increase suicidal thinking in young adults under 25 during initial treatment.
Drug Interactions
Major Interactions
MAOIs (contraindicated), CYP1A2 inhibitors (fluvoxamine dramatically increases duloxetine levels), heavy alcohol use (hepatotoxicity risk)
CYP Metabolism
Substrate of CYP1A2 and CYP2D6. Moderate inhibitor of CYP2D6.
Alcohol
Avoid alcohol during duloxetine treatment. Both affect the central nervous system, and the combination increases sedation, impairs judgment, and may worsen psychiatric symptoms.
Generic Versions & Cost
Generic duloxetine has been available since 2013. Approximate cost: $10–30/month. The generic contains the same active ingredient and is FDA-certified as bioequivalent to brand-name Cymbalta.
Starting Cymbalta: What to Expect
First Weeks
Duloxetine is typically started at 30mg/day and increased gradually based on your response and tolerability. The most common initial side effects — nausea, headache, and sleep changes — usually improve within the first 1–2 weeks. Full therapeutic benefit typically develops over 4–8 weeks.
When to Contact Your Psychiatrist
Contact your psychiatrist if you experience: worsening depression or anxiety, thoughts of self-harm, unusual agitation, severe side effects, signs of allergic reaction, or any concerning mood or behavioral changes.
Stopping Cymbalta Safely
Never stop duloxetine abruptly. Discontinuation can cause withdrawal symptoms including dizziness, nausea, irritability, and sensory disturbances. Your psychiatrist will develop a gradual tapering schedule.
Timeline: When Cymbalta Starts Working
Timeline to Effectiveness
Expected improvement trajectory over the first 8 weeks
Based on clinical trial data. Full therapeutic effects may take 6–8 weeks.
Get Cymbalta Prescribed by a Board-Certified Psychiatrist
At Psychiatry Telemed, duloxetine is prescribed by board-certified psychiatrists following comprehensive psychiatric evaluation. We serve all of Florida through HIPAA-compliant telepsychiatry. Most patients seen within 1–3 days. $200 initial evaluation, $100 follow-up.
Frequently Asked Questions
Duloxetine is prescribed for depression, generalized anxiety, chronic pain + depression, musculoskeletal pain. FDA-approved for MDD. Particularly effective when depression co-occurs with physical pain symptoms.
Initial improvement typically begins within 2–4 weeks, with full therapeutic benefit at 4–8 weeks. Your psychiatrist monitors progress at monthly appointments.
Common side effects include nausea, headache, drowsiness, insomnia, dry mouth, and dizziness. Most are mild and resolve within 1–2 weeks.
No. Duloxetine is not habit-forming. However, it should not be stopped abruptly — gradual tapering under psychiatric supervision is recommended.
Alcohol should be avoided. Both are CNS-active, and the combination increases sedation, impairs judgment, and may worsen symptoms.
Only SNRI with FDA approval for pain conditions (fibromyalgia, diabetic neuropathy, chronic musculoskeletal pain). Dual mood + pain mechanism makes it uniquely valuable for depression with somatic symptoms.
Authoritative Resources
Medical Disclaimer: This information is for educational purposes only and does not replace professional medical advice. Always consult with a board-certified psychiatrist before starting, stopping, or changing any medication. If you are experiencing a mental health crisis, call 988 or 911.
Last reviewed: